ACIU: AC Immune SA

ACIU新闻

• 14:37 SMMT Stock Soars on NSCLC Drug Survival Data Beating Keytruda in China
• 13:18 IONS Secures FDA Nod for Rare Brain Disorder Drug Zanvastro
• 15:49 Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?
• 15:43 FDA Accepts UTHR's sNDA for Tyvaso in Idiopathic Pulmonary Fibrosis
• 15:25 RARE Stock Down 46% as Phase III Angelman Syndrome Study Misses Goals
• 15:01 Here's Why You Should Add RNTX Stock to Your Portfolio Now
• 13:20 AZN's Tagrisso Plus Orpathys Study in First-Line NSCLC Meets Goal
• 13:05 KURA Stock Gains 37.6% in a Month: Here's What You Need to Know
• 16:32 BNTX Ends Colorectal Cancer Immunotherapy Study, Stock Down
• 14:03 LLY's Mounjaro Gets FDA Nod to Cut Cardiovascular Risk in Diabetes
• 14:58 Here's Why You Should Add ARQT Stock to Your Portfolio Now
• 14:41 Gilead Wins FDA Nod for Bixlenvo in Adults Living With HIV Infection
• 13:22 FDA Accepts United Therapeutics' NDA Filing for Ralinepag in PAH
• 14:57 AZN/AMGN's Tezspire Hits Primary Goal in Eosinophilic Esophagitis Study
• 13:42 BHVN Stock Soars 18% on $795M Out-Licensing Deal for Epilepsy Program
• 16:29 JAZZ Secures FDA Nod for Expanded Use of Ziihera in Gastric Cancer
• 16:10 SYRE Stock Sinks After Mixed SKYWAY Study Data in Rheumatoid Arthritis
• 15:07 RGNX Stock Slumps 25% on FDA Clinical Hold for RGX-121 Gene Therapy
• 14:09 Here's Why You Should Add ACET Stock to Your Portfolio Now
• 14:04 Acadia Gets European Commission Nod for Daybu in Rett Syndrome
• 15:39 Anika Stock Gains 43.4% in the Past 3 Months: Here Is Why?
• 16:40 TEVA's Ecopipam Wins FDA Priority Tag in Pediatric Tourette Syndrome
• 16:32 AC Immune Says Early Data from Anti-Inflammatory Drug Gives Wider Clinical Momentum for Pipeline - AC Imm
• 14:56 Reasons Why Investors Should Consider Betting on PGEN Stock